We are live on ! Find out more
PIP

Palisades Investment Partners Portfolio holdings

AUM $352M
1-Year Est. Return 76.79%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+76.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$237M
AUM Growth
+$7.26M
Cap. Flow
+$15.2M
Cap. Flow %
6.41%
Top 10 Hldgs %
52.44%
Holding
46
New
6
Increased
31
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$6.2M
2
WGS icon
GeneDx Holdings
WGS
+$5.84M
3
MWA icon
Mueller Water Products
MWA
+$5.6M
4
CRMD icon
CorMedix
CRMD
+$3.64M
5
TSSI
TSS Inc
TSSI
+$2.45M

Top Sells

Rank Stock Value
1
NSSC icon
Napco Security Technologies
NSSC
+$8.68M
2
BLBD icon
Blue Bird Corp
BLBD
+$8.5M
3
MSA icon
Mine Safety
MSA
+$4.55M
4
CWCO icon
Consolidated Water Co
CWCO
+$2.94M
5
GES
Guess Inc
GES
+$2.33M

Sector Composition

Rank Sector Weight
1 Healthcare 26.34%
2 Industrials 25.36%
3 Technology 23.72%
4 Consumer Discretionary 11.61%
5 Financials 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRL icon
1
Sterling Infrastructure
STRL
$16.8B
$19.5M 8.24%
115,956
+11,700
+11% +$2.02M
SPXC icon
2
SPX Corp
SPXC
$10.8B
$16.3M 6.88%
112,097
+10,109
+10% +$1.63M
INOD icon
3
Innodata
INOD
$2.07B
$14.6M 6.15%
368,651
+21,093
+6% +$665K
MMYT icon
4
MakeMyTrip
MMYT
$5.62B
$14.5M 6.12%
129,205
+11,439
+10% +$1.23M
MOD icon
5
Modine Manufacturing
MOD
$10.4B
$13M 5.49%
112,147
+10,775
+11% +$1.39M
INTA icon
6
Intapp
INTA
$2.86B
$10.6M 4.49%
166,013
+15,123
+10% +$867K
TMDX icon
7
Transmedics
TMDX
$2.8B
$9.98M 4.21%
160,108
+11,323
+8% +$1.05M
SPSC icon
8
SPS Commerce
SPSC
$2.64B
$9.12M 3.85%
49,548
+4,244
+9% +$796K
UFPT icon
9
UFP Technologies
UFPT
$2.43B
$8.54M 3.6%
34,927
+2,945
+9% +$857K
AVAV icon
10
AeroVironment
AVAV
$8.97B
$8.07M 3.41%
52,456
-905
-2% -$177K
BMI icon
11
Badger Meter
BMI
$4.04B
$7.2M 3.04%
33,951
+2,868
+9% +$625K
ADMA icon
12
ADMA Biologics
ADMA
$2.2B
$6.87M 2.9%
400,663
+51,658
+15% +$972K
VCYT icon
13
Veracyte
VCYT
$3.77B
$6.49M 2.74%
+163,809
New +$6.2M
WGS icon
14
GeneDx Holdings
WGS
$2.19B
$6.43M 2.71%
+83,604
New +$5.84M
KRYS icon
15
Krystal Biotech
KRYS
$9.58B
$6.34M 2.68%
40,479
+3,436
+9% +$610K
MC icon
16
Moelis & Co
MC
$4.96B
$5.65M 2.39%
76,526
+6,511
+9% +$471K
MWA icon
17
Mueller Water Products
MWA
$4.18B
$5.36M 2.26%
+238,316
New +$5.6M
MEDP icon
18
Medpace
MEDP
$16.3B
$5.29M 2.23%
15,919
+1,338
+9% +$454K
CAMT icon
19
Camtek
CAMT
$7.33B
$5.23M 2.21%
64,709
+5,789
+10% +$455K
SWTX
20
DELISTED
SpringWorks Therapeutics
SWTX
$4.86M 2.05%
134,445
+12,154
+10% +$425K
WLFC icon
21
Willis Lease Finance
WLFC
$1.29B
$4.34M 1.83%
62,784
+5,424
+9% +$351K
FFBC icon
22
First Financial Bancorp
FFBC
$3.54B
$4.05M 1.71%
150,711
+15,876
+12% +$433K
FISI icon
23
Financial Institutions
FISI
$823M
$3.78M 1.6%
138,527
+11,752
+9% +$309K
AMSC icon
24
American Superconductor
AMSC
$1.6B
$3.51M 1.48%
142,415
+12,317
+9% +$340K
ONTO icon
25
Onto Innovation
ONTO
$15.3B
$3.4M 1.44%
20,412
+1,771
+10% +$324K
1
2

Similar funds

ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Palisades Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Palisades Investment Partners held 46 positions worth $237M, up 3.2% from $230M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Palisades Investment Partners deployed $15.2M of net new capital in Q4 2024, opening 6 new positions and adding to 31 existing holdings. Its largest new stake was Veracyte: 163,809 shares worth $6.49M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was AeroVironment, an estimated $177K trimmed.

  • Palisades Investment Partners's largest Q4 2024 buy was Veracyte: 163,809 shares worth $6.49M.
  • Palisades Investment Partners added most to Sterling Infrastructure in Q4 2024, an estimated $2.02M increase.
  • Palisades Investment Partners's biggest Q4 2024 reduction was AeroVironment, cutting an estimated $177K.
  • Palisades Investment Partners fully exited Napco Security Technologies in Q4 2024, selling an estimated $8.68M.
  • Palisades Investment Partners's ten largest holdings make up 52% of its $237M portfolio in Q4 2024.
  • Palisades Investment Partners opened 6 new positions and closed 5 in Q4 2024.
  • Palisades Investment Partners's portfolio value rose 3.2% quarter-over-quarter to $237M.

Based on Palisades Investment Partners's 13F filing for Q4 2024, filed 18 Feb 2025.